Bentley Systems’s (NASDAQ:BSY) Q2 CY2026 Earnings Results: Revenue In Line With Expectations

Bentley Systems (NASDAQ:BSY) reported Q2 CY2026 revenue of $410.7 million, up 12.8% year on year and in line with Wall Street expectations, with non-GAAP EPS of $0.35, 9.8% above consensus. ARR was $1.54 billion, net revenue retention was 109%, and the stock fell 3.6% to $34.74 after results.

Original reporting
Published Aug 6, 2026, 12:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 1:06 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Bentley Systems’s (NASDAQ:BSY) Q2 CY2026 Earnings Results: Revenue In Line With Expectations — source image
Decision brief

The 30-second read

$BSYNeutralMed
01

Why it matters

Q2 CY2026 shows revenue in-line with consensus and EPS above consensus, but billings slightly missed and growth decelerated versus its longer-term trend. The stock reaction (-3.6%) implies investors prioritized the softer demand signal over the EPS beat.

02

Market read

Traders can reassess near-term expectations for infrastructure software demand using the combination of in-line revenue, EPS beat, ARR growth pace, and retention metrics.

03

What to watch

The article highlights decelerating growth (11.6% annualized over two years) but does not quantify guidance details beyond revenue growth expectations, limiting conviction on forward demand inflection.

Relevance 7/10Novelty 6/10Timing: post-Q2 results, immediately after-hours move to $34.74

Background

Bentley Systems is an infrastructure engineering software provider focused on digital twins, with performance often judged by ARR growth, retention, and billings.

Company-level read

Ticker impact

$BSYNeutralMedium confidence
Context

Bentley Systems reported Q2 CY2026 revenue of $410.7M, up 12.8% YoY, in line with expectations, with non-GAAP EPS $0.35 beating consensus.

Expected impact

Near-term bias likely neutral to slightly negative unless investors focus on ARR retention and any billings rebound.

Evidence & confidence

The article provides concrete earnings datapoints (revenue, EPS, ARR, retention, billings miss) and notes an immediate -3.6% reaction, suggesting the market discounted the quarter despite EPS outperformance.

Market effects

Signals continued deceleration risk for infrastructure engineering software, despite solid retention and ARR scale.

Primarily US-listed software sentiment; limited direct regional spillover described.

Digital-twins/infrastructure software demand read-through, but no global macro or policy linkage provided.

Counterpoint

The 109% net revenue retention and ARR of $1.54B suggest underlying customer expansion remains healthy, which could offset concerns about billings softness.

Key entities

  • Bentley Systems

    Reported Q2 CY2026 revenue, non-GAAP EPS, ARR, net revenue retention, and billings vs expectations.

Related articles

$BSYMed

Why is Bentley Systems stock sliding today?

Bentley Systems (BSY) shares fell about 2.9% pre-open after Q2 2026 results. Adjusted EPS was $0.35 versus $0.32 expected, but revenue was $410.7M, below the ~$412.2M consensus and down from $424.2M in Q1. Subscriptions rose 13.6% YoY to $378.6M. Analysts kept a consensus buy and ~$44 target.

$BSYMedAI 8/10

BENTLEY SYSTEMS INC (BSY): Results of Operations and Financial Condition

BENTLEY SYSTEMS INC (BSY) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 a26q2exhibit991.htm EX-99.1 Document Exhibit 99.1 Bentley Systems Announces Second Quarter 2026 Results EXTON, PA – August 6, 2026 – Bentley Systems, Incorporated (Nasdaq: BSY), the infrastructure engineering software company, today announced results for the quarter end

$UNHMed

Antitrust & Competition Healthcare 1H 2026 Update

The article reviews US antitrust enforcement in healthcare in 1H 2026, highlighting the FTC’s March 20 launch of a Healthcare Task Force. It cites FTC-required divestitures in Sevita’s $835M BrightSpring deal and Ascension’s $3.9B AmSurg deal, plus PBM settlements reshaping rebate models, including Express Scripts and Optum. It also notes ongoing DOJ/State focus on payor contracting and algorithmic pricing.

$BSYMedAI 8/10

12 Best High Short Interest Stocks With Highest Upside Potential

BNN Bloomberg (May 29) quoted Investment Decision Research’s Melissa Brown saying inflation above the Fed’s 2% target is pressuring bond yields and could weigh on stocks and bonds. She cited strong Q1 earnings partly from a “stock market wealth effect” amid low consumer sentiment (44.8). The article lists 12 high short-interest stocks; examples include Bentley Systems (Q1 2026 revenue $424.2M, FCF $187.9M) and Spyre Therapeutics (pro forma cash $1.2B).

$LEEMed

Lee Enterprises, Incorporated Q3 2026 Earnings Call Summary

Lee Enterprises reported Q3 2026 progress toward a digital-first model, saying digital revenue was 57% of total revenue. It cited a 15% cash cost reduction and fifth straight quarter of comparable adjusted EBITDA growth, raising full-year adjusted EBITDA guidance to 22% to 28%. The company expects about $18M annual interest savings, positive net income of $5.2M, and plans debt paydown using excess cash and non-core asset sales.

$LNGMed

Cheniere Energy, Inc. Q2 2026 Earnings Call Summary

Cheniere Energy’s Q2 2026 call cited production outperformance and faster Corpus Christi Stage 3 startup for a second guidance raise. Full-year 2026 adjusted EBITDA guidance was revised to $7.9B-$8.4B. Management expects Sabine Pass Phase 1 FID by early 2027, targets dividend growth of at least 10% annually, and issued $1.75B dual-tranche bonds extending maturities to 2056.